LDS/Medical Tests/Interleukin 2 (IL2) Soluble Receptor Alpha

Interleukin 2 (IL2) Soluble Receptor Alpha

The interleukin-2 receptor is composed of three subunits, interleukin-2 receptor alpha (IL-2Ra), interleukin-2 receptor beta (IL-2Rb), and interleukin-2 receptor gamma (IL-2Rγ). Interleukin 2 receptor alpha (IL-2Rα), also known as CD25 or the Tac antigen, is a type 1 transmembrane glycoprotein found on the cytoplasm side of the membrane. Normal levels of IL-2Ra are seen in patients with healthy immune systems. IL2Rα is present on activated T cells, but is also found in serum in a soluble form when increased. Increased levels of the soluble IL-2Rα in serum correlate with activation of T and/or B cells and the activation of the immune system as seen in many autoimmune disorders such as transplant rejection, Lupus Erythematosus (SLE), and rheumatoid arthritis (RA). IL-2Rα is also increased in some leukemias and lymphomas due to the presence of IL-2Ra expression on Natural Killer Cells (NK cells) and lymphoma cells. IL-2Rα levels can also be useful in the prognosis in non-Hodgkin lymphoma patients. Monitoring the disease activity of HIV patients is easily correlated with the presence of IL-2Ra in the serum because of the increased amounts seen in immune system activation. Increased amounts of IL-2Ra levels over time can create an imbalance in immune system activation and create a susceptibility to many types of infections. Decreased amounts of IL-2Ra are seen in activated T-cell deficiencies, in loss from apoptosis, polycystic kidney disease (PKD), some cancers, and in IL-2 deficiencies.

  • As an aid in prognosis and management of patients with leukemia or lymphoma
  • Monitor therapy in lymphoma/leukemia patients
  • Monitor therapy in HIV patients
  • Monitor patients post transplant for rejection
  • Aid in diagnosis of some autoimmune disorders

Increased in:

  • T- or B-cell Lymphomas
  • Hairy cell leukemia
  • Lupus Erythematosus
  • Rheumatoid arthritis
  • HIV
  • Non-Hodgkin lymphoma
  • Infection
  • Inflammation
  • Some other autoimmune diseases
  • Trauma

Decreased in:

  • Activated T-cell deficiency
  • Apoptosis
  • Polycystic Kidney Disease (PKD)
  • IL-2 deficiency

0-1033 pg/mL
 

 

 

Electrochemiluminescence immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA), LC/MS. 

Serum (SST) or Plasma EDTA (Lavender),Heparin (Green). 

Separate serum or Plasma and keep frozen.

Stability

  • Ambient: 24 hours
  • Refrigerated: Unacceptable
  • Frozen: 30 days
Flow cytometry panel, CBC with differential, IL-2 receptor assay, CRP, Complement system, Tumor necrosis factor Alpha, Interleukin 6.

1-2 weeks. 

Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login